UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from _________ to _________ Commission file number: 001-39785 LIFEMD, INC. (Registrant's telephone number, including area code) Securities registered pursuant to Section ...

LifeMD, Inc. (NASDAQ:LFMD) Q2 2023 Earnings Call Transcript August 9, 2023 4:30 PM ET Company Participants Justin Schreiber - Chairman and Chief Executive Officer Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG, LLC Sarah James - Cantor Fitzgerald Operator Good afternoon. Thank you for joining us today to discuss the results for LifeMD's Second Quarter ended June 30, 2023, Joining the call today are Justin Schreiber, Chairman and Chief Executive Officer; and Marc Ben ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from _________ to _________ Commission file number: 001-39785 LIFEMD, INC. (Exact name of registrant as specified in its charter) Delaware 76-0238453 (State or other Jurisdict ...

9:41 "| 之 ■ LifeMD! ( Welcome to LifeMD! Explore your LifeMD dashboard. ឞ Check my symptoms See a provider Paid g Today Tomorrow Si ASAP Jan 23 Jan 24 Jai -10 min wait PRESCRIPTIONS Use my discount card Save up to 80% on prescription = medications. View card > MY CHART The Doctor Will See You Now May 2023 NASDAQ: LFMD This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amende ...

LifeMD, Inc. (NASDAQ:LFMD) Q1 2023 Earnings Conference Call May 12, 2023 8:30 AM ET Company Participants Justin Schreiber - Chairman and Chief Executive Officer Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG, LLC Operator Good morning. Thank you for joining us today to discuss the results for LifeMD's First Quarter ended March 31, 2023. Joining the call today are Justin Schreiber, Chairman and Chief Executive Officer; and Marc Benathen, Chief Financial Officer of Li ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from _________ to _________ Commission file number: 001-39785 LIFEMD, INC. (Exact name of registrant as specified in its charter) Delaware 76-0238453 (State or other Jurisdic ...

Call Start: 17:00 January 1, 0000 5:33 PM ET LifeMD, Inc. (NASDAQ:LFMD) Q4 2022 Earnings Conference Call March 22, 2023, 17:00 ET Company Participants Justin Schreiber - Chairman & CEO Marc Benathen - CFO Conference Call Participants David Larsen - BTIG Operator Good afternoon. Thank you for joining us today to discuss the results for LifeMD's Fourth Quarter and Full Year ended December 31, 2022. Joining the call today are Justin Schreiber, Chairman and Chief Executive Officer; and Marc Benathen, Chief Fina ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________________ to __________________________ Commission file number 001-39785 LIFEMD, INC. (Exact name of registrant as specified in its charter) Delaw ...

LifeMD, Inc. (NASDAQ:LFMD) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Justin Schreiber – Chief Financial Officer Marc Benathen – Chierf Financial Officer Conference Call Participants David Larsen – BTIG Marc Wiesenberger – B. Riley Securities Operator Good afternoon. Thank you for joining us today to discuss the results for LifeMD’s Third Quarter Ended September 30, 2022. Joining the call today are Justin Schreiber, Chairman and Chief Executive Officer; and Marc Benat ...

LifeMD: Q2 2022 Supplemental Investor Highlights Presentation Highlights Liquidity: We ended Q2 with $12 million in cash. For the firsttime ever, we reduced our consolidated burn rate in June to below $1M. We are on track to achieve Consolidated Adjusted EBITDA profitability by Q4 and on track to divest WorkSimpli by Q4. Virtual Primary Care: Our recently launched virtual primary care (VPC) platform saw a 1,500% increase in subscriber count during Q2. As of August 10th, we have more than 1,200 VPC subscribe ...